Stock listing
Frankfurt:AJ8 Agenus Inc. Aktie
German listing (Frankfurt) of Agenus Inc. · home listing NASDAQ:AGEN
Follow Agenus Inc. into a list and get an email when it puts out news.
Share price · FWB:AJ8
€6.10 EUR +0.65 (+11.9%)
Close on Oct 30, 2026
- Day range
- €6.10 – €6.25 EUROct 30, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:AGEN · Home | $6.84 USD | -0.25 (-3.5%) | 564,302 | $6.91 | $7.09 | $6.69 | $7.09 | Close on Oct 30, 2026 |
| Frankfurt:AJ8 | €6.10 EUR | +0.65 (+11.9%) | — | €6.25 | €6.25 | €6.10 | €5.45 | Close on Oct 30, 2026 |
- Ticker
- Frankfurt:AJ8
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 25, 2026
Agenus Reports 72% of Patients with Locally Advanced dMMR Colon Cancer Had No Cancer Remaining at Surgery Following Six Weeks of BOT+BAL in Phase 2 NEOASIS Study at ESMO 2026
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 33 slides
Calls
Replays
Agenus (NASDAQ:AGEN) Q2 2025 Earnings Call
Wed, Aug 27, 2025 · 9:30 AM ET
Watch TranscriptAgenus (NASDAQ:AGEN) Q4 2024 Earnings Call
Tue, Mar 11, 2025 · 8:30 AM ET
Watch TranscriptAgenus (NASDAQ:AGEN) Q3 2024 Earnings Call
Tue, Nov 12, 2024 · 8:30 AM ET
Watch Transcript
Latest news
Financings
Private placement of common stock or pre-funded warrants with Series A and Series B purchase warrants
Jul 13, 2026
Announced: US$85M–US$340M · an accompanying Series A purchase warrant and Series B purchase warrant that, if fully…
Buyers: Commodore Capital; RA Capital Management; TCGX; Invus; Ligand Pharmaceuticals
Use of proceeds: Advance BOT+BAL in neoadjuvant MSS colon cancer, including the registrational Phase 3 ROBBIN trial
Decks
Investor Presentation (October 2026)
Investor deck · 33 slides · October 2026
Corporate Update (July 2026)
Corporate update · 31 slides · Jul 13, 2026
Agenus Corporate Event at ESMO 2023
Conference · 34 slides · Oct 22, 2023
Investor Day (November 2022)
Investor day · 131 slides · Nov 12, 2022
Agenus Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 43 in the last 12 months · 180 in all · newest Oct 25, 2026 · oldest 2019
- Calls
- 14 calls with a replay · 14 with a transcript · latest Aug 27, 2025
- Decks
- 25 decks · latest October 2026
Where Agenus Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:AGEN · Home listing | NASDAQ | United States | USD |
| LS Exchange:A403RK | LS Exchange | Germany | EUR |
| Lang & Schwarz:A403RK | Lang & Schwarz | Germany | EUR |
| gettex:AJ8 | gettex | Germany | EUR |
| BX Swiss:AGEN | BX Swiss | Switzerland | CHF |
| BOATS:AGEN | BOATS | United States | USD |
| Dusseldorf:AJ8 | Dusseldorf | Germany | EUR |
| Frankfurt:AJ8 · This page | Frankfurt | Germany | EUR |
| Munich:AJ8 | Munich | Germany | EUR |
| Tradegate:AJ8 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Agenus Inc.